Techh.info/biomedtechnology hourly

Headlines

headlines texts
18.09.2019
08:06 News-Medical.NetStudy: Gene editing may correct genetic mutation responsible for Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a rare but devastating genetic disorder that causes muscle loss and physical impairments.

Скрыть анонс
05:52 News-Medical.NetNew results revealed from pilot stem cell study for stroke

Researchers led by Sean I. Savitz, MD, reported today in the journal Stem Cells that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

Скрыть анонс
17.09.2019
21:09 ScienceDaily.comGene editing enables researchers to correct mutation in muscle stem cells in DMD model

Duchenne muscular dystrophy (DMD) is a rare but devastating genetic disorder that causes muscle loss and physical impairments. Researchers have shown in a mouse study that the powerful gene editing technique known as CRISPR may provide the means for lifelong correction of the genetic mutation responsible for the disorder.

Скрыть анонс
21:02 WhatReallyHappened.comPioneering stem cell injections boost recovery in 25 stroke patients 'by helping damaged nerve cells regrow within six months'

The trial is among the first times the therapy has been tested on human patients Their own bone marrow cells were put into their blood within 72 hours of stroke One scientist said their nerve cells were regrowing in a way not usually seen More than 100,000 strokes happen annually in the UK and 795,000 in the US By SAM BLANCHARD SENIOR HEALTH REPORTER FOR MAILONLINE
PUBLISHED: 09:00 EDT, 17 September 2019 | UPDATED: 11:48 EDT, 17 September 2019

Скрыть анонс
20:37 News-Medical.NetComputer scientist wins $2.3 million to develop AI that patients can use to manage health

Samantha Kleinberg, a computer scientist at Stevens Institute of Technology and pioneer in wearable technologies, has secured roughly $2.3 million in three new grants by the National Science Foundation and the National Institutes of Health to develop artificial intelligence that provides personalized information to patients so they can take an active part in managing their health.

Скрыть анонс
17:02 CNN HealthMale breast cancer screening in high-risk patients extremely successful, study says

Mammograms are more effective at detecting breast cancer in high-risk men than in women who are at average risk of developing the disease, and could provide potentially lifesaving early detection of male breast cancer.

Скрыть анонс
15:14 News-Medical.NetPros and cons of gene editing technology

CRISPR technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal "Trends in Cell Biology" from 12 September 2019.

Скрыть анонс
12:00 Technology.orgCase Western Reserve University and Akouos sign exclusive licensing agreement to advance development of gene therapy technology as a potential treatment for a type of Usher syndrome

Case Western Reserve University and Boston-based Akouos have entered into an exclusive licensing agreement to develop a patented gene therapy with

Скрыть анонс
01:33 FT.com TechnologyCMR Surgical hits £1bn valuation as it rolls out robots for surgery

Cambridge-based start-up raises £195m as it prepares to launch in Europe and India

Скрыть анонс
01:33 FT.com HealthCMR Surgical hits £1bn valuation as it rolls out robots for surgery

Cambridge-based start-up raises £195m as it prepares to launch in Europe and India

Скрыть анонс
00:29 ScienceDaily.comBig data, bench science suggests drug may slow Parkinson's progression in people

A drug used to treat enlarged prostate may also slow the progression of Parkinson's disease, according to a new study.

Скрыть анонс
16.09.2019
23:11 FierceBiotech.comProstate drug may slow Parkinson’s progression, big data suggests

Terazosin, a decades-old drug to treat enlarged prostate, could provide a new way to address Parkinson’s disease by targeting PGK1, scientists at Capital Medical University in Beijing and the University of Iowa found.

Скрыть анонс
18:39 BBC HealthOscar Saxelby-Lee: Cancer returns after stem cell transplant

Oscar's family aim to raise £500,000 to pay for further treatment they say is not available on the NHS.

Скрыть анонс
16:39 ScienceDaily.comTransplanted brain stem cells survive without anti-rejection drugs in mice

In experiments in mice, researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

Скрыть анонс
16:33 TechInvestorNews.comGoogle Maps adds tools to help people recover from drug, alcohol addiction (Aaron Mamiit/Digital Trends)

Aaron Mamiit / Digital TrendsGoogle Maps adds tools to help people recover from drug, alcohol addiction - Google Maps, as part of National Recovery Month, added two new features that will support people on the path to recovery from drug or alcohol addiction. ...

Скрыть анонс
16:19 News-Medical.NetResearchers eliminate need for anti-rejection drugs in mice with transplanted glial cells

In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

Скрыть анонс
15:57 Technology.orgScientists use CRISPR to Treat HIV for the First Time

The patient in question – a 27-year-old male citizen of China – was diagnosed with AIDS back in

Скрыть анонс
13:34 TechInvestorNews.comHands on with the Xidu PhilPad tablet: A well performing low cost Microsoft Surface clone (ZDNet Latest News)

ZDNet Latest NewsHands on with the Xidu PhilPad tablet: A well performing low cost Microsoft Surface clone - The Xidu PhilPro 2 in 1 tablet includes an attachable keyboard and stylus in this low cost Windows tablet ...

Скрыть анонс
08:40 TechInvestorNews.comUser experience in medical AI must be enhanced, says Microsoft Taiwan COO (DigiTimes: IT news from Asia)

DigiTimes: IT news from AsiaUser experience in medical AI must be enhanced, says Microsoft Taiwan COO - While accuracy in AI-based interpretation of medical images is improving, the user experience - mainly for doctors and nurses - and accessibility of the technology to them should be enhanced, says Microsoft Taiwan chief operating officer (COO) Hedy Ho. ...

Скрыть анонс
14.09.2019
01:11 MedicalNewsToday.comMedical News Today: Calorie restriction plus exercise can make bones more fragile

New research in female mice reveals that exercising while on a low calorie diet can decrease quality and quantity of bone instead of increasing robustness.

Скрыть анонс
13.09.2019
23:40 Phys.orgScientists sharpen gene editing tool

Wake Forest Institute for Regenerative Medicine scientists have fine-tuned their delivery system to deliver a DNA editing tool to alter DNA sequences and modify gene function. The improved "hit and run" system works faster and is more efficient.

Скрыть анонс
23:01 ScienceDaily.comGene editing tool gets sharpened by WFIRM team

Scientists have fine-tuned their delivery system to deliver a DNA editing tool to alter DNA sequences and modify gene function. The improved 'hit and run' system works faster and is more efficient.

Скрыть анонс
19:12 News-Medical.NetCRISPR may explain why so many experimental cancer drugs fail

Scientists have used CRISPR–Cas9 to investigate how ten cancer drugs interact with their protein target, revealing some intriguing findings.

Скрыть анонс
18:57 ScientificAmerican.ComLab-Grown Human Mini Brains Show Brainy Activity

As the little structures grow, their constituents specialize into different types of brain cells, begin to form connections and emit brain waves. They could be useful models for development and... -- Read more on ScientificAmerican.com

Скрыть анонс
17:58 ScientificAmerican.ComLab-Grown Human Minibrains Show Brainy Activity

As the little structures grow, their constituents specialize into different types of brain cells, begin to form connections and emit brain waves. They could be useful models for development and... -- Read more on ScientificAmerican.com

Скрыть анонс
14:50 CNNCRISPR tool used on HIV patient for first time

The 27-year-old patient's prospects were bleak. In May 2016, he found out he had AIDS. Two weeks later, he was told he had acute lymphoblastic leukemia.

Скрыть анонс
13:07 News-Medical.NetDiscovery opens up new opportunities to understand the genetics of cancer

University of Delaware molecular biologist Mona Batish and collaborators at Harvard Medical School and University of California, Los Angeles, have identified a new circular ribonucleic acid (RNA) that increases tumor activity in soft tissue and connective tissue tumors.

Скрыть анонс
12:43 Technology.orgScientists discover new breakthrough in cancer hair loss treatment

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent

Скрыть анонс
12:07 Technology.orgTissue Type

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have

Скрыть анонс
12:05 News-Medical.NetHCV-infected donor kidneys are safe and functional one year post-transplantation

A recent analysis reveals that kidneys from donors infected with hepatitis C virus are now routinely used in transplants at many U.S. centers, and they are functioning well one year after transplantation.

Скрыть анонс
11:05 Technology.orgArtificial Intelligence That Reads Chest X-Rays Is Approved by FDA

New artificial intelligence-powered technology may soon help reduce delays in diagnosing a collapsed lung, or pneumothorax, which is

Скрыть анонс
10:02 CNN HealthChinese scientists use CRISPR tool on HIV patient for the first time

A Chinese team from Peking University have used gene editing tool CRISPR-Cas9 on a HIV patient for the first time. They managed to create stem cells resistant to the disease, but weren't able to cure him.

Скрыть анонс
06:39 CNN HealthHepatitis C-infected kidneys function as well as others after transplant, study says

More transplant centers are willing to use kidneys infected with hepatitis C. With advances in treatment for hepatitis C, a new study finds the organs are viable and won't make a recipient ill.

Скрыть анонс
01:46 News-Medical.NetNew gene therapy helps stroke patients develop new neurons

Ischemic stroke is a condition in which parts of the brain lose their blood supply, causing nerve damage. Once brain tissue suffers irreparable harm, the patient will experience irreversible disability or death, depending on the extent of neuronal loss.

Скрыть анонс
01:23 Medscape.ComFDA Clears GE Healthcare's AI Triage Algorithm on X-Ray Device

The algorithm analyses chest x-rays for pneumothorax and flags suspected cases for radiologists to prioritize.

Скрыть анонс
01:08 Nature.ComPublisher Correction: Asymmetric lysosome inheritance predicts activation of haematopoietic stem cells

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
12.09.2019
22:39 News-Medical.NetArtificial intelligence helps improve diagnosis of head and neck cancers

Researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium have successfully solved a longstanding problem in the diagnosis of head and neck cancers.

Скрыть анонс
21:03 ScienceDaily.comStem cell researchers reactivate 'back-up genes' in the lab

Scientists have unraveled parts of a mechanism that may one day help to treat Rett syndrome and other genetic disorders linked to the X chromosome.

Скрыть анонс
20:33 TechInvestorNews.comOracle tanks after CEO Mark Hurd takes indefinite medical leave (ORCL) (Ben Winck/Business Insider: Finance)

Ben Winck / Business Insider: FinanceOracle tanks after CEO Mark Hurd takes indefinite medical leave (ORCL) - Oracle stock fell as much as 6% on Thursday after the company said co-CEO Mark Hurd would take a leave of absence for health reasons. Company founder and chief technology officer Larry Ellison will assume Hurds responsibilities alongside his co-CEO Safra Catz. The announcement didnt detail Hurds health issues or ...

Скрыть анонс
20:22 Drugs.comAHA News: Unique Gene Activity Discovered in People With Both Stroke and Cancer

THURSDAY, Sept. 12, 2019 (American Heart Association News) -- Not all strokes have a clear-cut cause like high blood pressure or smoking. For those so-called cryptogenic strokes, new research suggests cancer might be the trigger – a finding that...

Скрыть анонс
20:10 Phys.orgStem cell researchers reactivate 'back-up genes' in the lab

Biomedical scientists at KU Leuven have unraveled parts of a mechanism that may one day help to treat Rett syndrome and other genetic disorders linked to the X chromosome.

Скрыть анонс
19:58 News-Medical.NetScientists attempt to cure HIV using CRISPR, with varying results

Scientists have used the gene-editing technology CRISPR in an attempt to cure a person infected with HIV, with some success.

Скрыть анонс
19:41 ScienceDaily.comScientists discover new breakthrough in cancer hair-loss treatment

Researchers have discovered a new strategy for how to protect hair follicles from chemotherapy, which could lead to new treatments that prevent chemotherapy-induced hair loss -- arguably one of the most psychologically distressing side effects of modern cancer therapy.

Скрыть анонс
19:35 TechInvestorNews.comOracle tanks after CEO Mark Hurd takes indefinite medical leave (ORCL) (Ben Winck/Business Insider: Finance)

Ben Winck / Business Insider: FinanceOracle tanks after CEO Mark Hurd takes indefinite medical leave (ORCL) - Oracle stock fell as much as 6% on Thursday after the company said co-CEO Mark Hurd would take a leave of absence for health reasons. Company founder and chief technology officer Larry Ellison will assume Hurds responsibilities alongside his co-CEO Safra Catz. The announcement didnt detail Hurds health issues or ...

Скрыть анонс
17:38 WhatReallyHappened.comGoogle bans ads for unproven medical treatments

Скрыть анонс
15:30 TechInvestorNews.comOracle CEO Mark Hurd takes leave of absence for health-related reasons as company reports disappoint (Graeme.Burton@incisivemedia.com(Graeme Burton)/Computing.co.uk Latest updates)

Graeme.Burton@incisivemedia.com(Graeme Burton) / Computing.co.uk Latest updatesOracle CEO Mark Hurd takes leave of absence for health-related reasons as company reports disappoint - Hurd will nevertheless continue to receive all employment benefits during his leave of absence from Oracle ...

Скрыть анонс
13:06 News-Medical.NetBIA Separations launches Cornerstone AAV Process Development Service to improve gene therapy production

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic products.

Скрыть анонс
13:06 Phys.orgBreakthrough stem cell platform could shed light on mysteries of early human development

A new method for making stem cell colonies that mimic parts of early human development could help investigate important questions in maternal and child health, such as: What chemicals pose risks to developing embryos, and what causes certain birth defects and multiple miscarriages?

Скрыть анонс
13:06 Google news Sci/TechChinese Scientists Tried to Treat HIV Using CRISPR - Livescience.com

Chinese Scientists Tried to Treat HIV Using CRISPR  Livescience.comChinese Scientists Edit DNA in Attempt to Cure Man’s Cancer, HIV  Yahoo FinanceScientists Break Ground In Use of Gene-Editing Tool  NewserChina is dividing the world over genetic engineering research  The IndependentChinese Scientists Try to Cure One Man's HIV With Crispr  WIREDView full coverage on Google News

Скрыть анонс
11:51 Technology.orgBreakthrough stem cell platform could shed light on mysteries of early human development

A new method for making stem cell colonies that mimic parts of early human development could help investigate

Скрыть анонс
11:39 TechInvestorNews.comGoogle puts drug addiction recovery info front and center (Engadget)

EngadgetGoogle puts drug addiction recovery info front and center - The opioid epidemic is responsible for tens of thousands of deaths per year. Google hopes to make it easier for the 23 million Americans in recovery to find a support group or find a pharmacy where they can purchase naloxone, the opioid-overdose reversal drug. The tech giant announced today that ...

Скрыть анонс
11:02 Technology.orgYoung transplant recipient gets 3-D models of his damaged heart

When Mason Thomas needed a heart transplant at age six, he asked to see his damaged heart so

Скрыть анонс
09:36 News-Medical.NetTest-1 BIA Separations introduces Cornerstone AAV Process Development Service to accelerate gene therapy production

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic products.

Скрыть анонс
07:05 Google news Sci/TechScientists Break Ground In Use of Gene-Editing Tool - Newser

Scientists Break Ground In Use of Gene-Editing Tool  NewserChinese Scientists Try to Cure One Man's HIV With Crispr  WIREDChinese Scientists Edit DNA in Attempt to Cure Man’s Cancer, HIV  Yahoo FinanceScientists use gene-edited stem cells to treat HIV — with mixed success  Nature.comCRISPR Gene-Editing Shows Promise As HIV Cure, Research Shows : Shots - Health News  NPRView full coverage on Google News

Скрыть анонс
05:00 Google news Sci/TechOracle C.E.O. Mark Hurd Is Taking a Medical Leave - The New York Times

Oracle C.E.O. Mark Hurd Is Taking a Medical Leave  The New York TimesOracle CEO Mark Hurd to take a leave of absence for health reasons  CNBCOracle Co-CEO Mark Hurd Taking Medical Leave  The Wall Street JournalOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue  Yahoo FinanceStocks making the biggest moves after hours: Oracle, Aurora Cannabis and more  CNBCView full coverage on Google News

Скрыть анонс
04:39 TechInvestorNews.comOracle C.E.O. Mark Hurd Is Taking a Medical Leave (Don Clark/New York Times - Technology)

Don Clark / New York Times - TechnologyOracle C.E.O. Mark Hurd Is Taking a Medical Leave - The software giant said a week before its annual conference that Mr. Hurd, one of its two chief executives, would step away. ...

Скрыть анонс
03:42 Google news Sci/TechScientists use gene-edited stem cells to treat HIV — with mixed success - Nature.com

Scientists use gene-edited stem cells to treat HIV — with mixed success  Nature.comChinese Scientists Try to Cure One Man's HIV With Crispr  WIREDChinese Scientists Edit DNA in Attempt to Cure Man’s Cancer, HIV  Yahoo FinanceA gene-editing first: scientists tried CRISPR to fight HIV  The Associated PressChinese Scientists Tried to Treat HIV Using CRISPR  Livescience.comView full coverage on Google News

Скрыть анонс
03:32 TechInvestorNews.comUPDATE 2-Oracle CEO Mark Hurd takes medical leave; first-quarter revenue misses (Reuters: Company News)

Reuters: Company NewsUPDATE 2-Oracle CEO Mark Hurd takes medical leave; first-quarter revenue misses - Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a medical leave, and the business software maker posted first-quarter revenue that missed Wall Street expectations. ...

Скрыть анонс
03:32 TechInvestorNews.comOracle CEO Mark Hurd takes medical leave; first-quarter revenue misses (Reuters: Business News)

Reuters: Business NewsOracle CEO Mark Hurd takes medical leave; first-quarter revenue misses - Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a medical leave, and the business software maker posted first-quarter revenue that missed Wall Street expectations. ...

Скрыть анонс
02:46 Google news Sci/TechMark Hurd, the co-CEO of Oracle, is taking a leave of absence, citing health reasons - TechCrunch

Mark Hurd, the co-CEO of Oracle, is taking a leave of absence, citing health reasons  TechCrunchOracle (ORCL) earnings Q1 2020: Mark Hurd takes leave of absence  CNBCOracle Co-CEO Mark Hurd Taking Medical Leave  The Wall Street JournalOracle stock slips as revenue comes up short, Hurd takes leave  MarketWatchStocks making the biggest moves after hours: Oracle, Aurora Cannabis and more  CNBCView full coverage on Google News

Скрыть анонс
02:34 Reuters.com TechnologyOracle CEO Mark Hurd takes medical leave; first-quarter revenue misses

Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a medical leave, and the business software maker posted first-quarter revenue that missed Wall Street expectations.

Скрыть анонс
02:33 News-Medical.NetNew model for vaginal microbiome transplantation

Bacterial vaginosis is a condition affecting thousands of women worldwide, and is associated not only with vaginal symptoms but with pregnancy-related complications including preterm labor and stillbirth. Now researchers have come up with an effective way to replace the unhealthy vaginal microflora with a ready-to-use microbiome – called a vaginal microbiome transplantation (VMT).

Скрыть анонс
02:21 NYT TechnologyOracle C.E.O. Mark Hurd Is Taking a Medical Leave

The software giant said a week before its annual conference that Mr. Hurd, one of its two chief executives, would step away.

Скрыть анонс
02:06 ScienceDaily.comGene therapy helps functional recovery after stroke

A new gene therapy turns glial cells -- abundant support cells in the brain -- into neurons, repairing damage that results from stroke and significantly improving motor function in mice.

Скрыть анонс
01:48 Google news Sci/TechOracle Chief Executive Officer Mark Hurd to Take a Leave of Absence for Health Related Reasons - PRNewswire

Oracle Chief Executive Officer Mark Hurd to Take a Leave of Absence for Health Related Reasons  PRNewswireOracle CEO Mark Hurd to take a leave of absence for health reasons  CNBCOracle Co-CEO Mark Hurd Taking Medical Leave  The Wall Street JournalOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue  Yahoo FinanceOracle CEO Mark Hurd to Take Leave to Focus on Health  BloombergView full coverage on Google News

Скрыть анонс
01:36 TechInvestorNews.comOracle CEO Mark Hurd to take a leave of absence for health reasons (CNBC: Top News)

CNBC: Top NewsOracle CEO Mark Hurd to take a leave of absence for health reasons - Oracles Mark Hurd, who was hired by founder Larry Ellison in 2010, is taking a leave of absence, the company said on Wednesday. ...

Скрыть анонс
01:36 TechInvestorNews.comOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue (Reuters: Money News)

Reuters: Money NewsOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue - Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a leave of absence due to health-related reasons, and the business software maker posted first-quarter revenue that missed Wall Street expectations. ...

Скрыть анонс
01:36 TechInvestorNews.comUPDATE 1-Oracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue (Reuters: Company News)

Reuters: Company NewsUPDATE 1-Oracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue - Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a leave of absence due to health-related reasons, and the business software maker posted first-quarter revenue that missed Wall Street expectations. ...

Скрыть анонс
01:36 TechInvestorNews.comOracle CEO Mark Hurd to take leave on health grounds (Reuters: Company News)

Reuters: Company NewsOracle CEO Mark Hurd to take leave on health grounds - Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a leave of absence due to health-related reasons. ...

Скрыть анонс
01:36 Google news Sci/TechCRISPR-Edited Cells That Block HIV Last Over a Year Without Side Effects, Study Shows - ScienceAlert

CRISPR-Edited Cells That Block HIV Last Over a Year Without Side Effects, Study Shows  ScienceAlertChinese Scientists Try to Cure One Man's HIV With Crispr  WIREDCRISPR Gene-Editing Shows Promise As HIV Cure, Research Shows : Shots - Health News  NPRA gene-editing first: scientists tried CRISPR to fight HIV  The Associated PressIn a CRISPR first, therapy aiming to cure HIV patient appears safe  STATView full coverage on Google News

Скрыть анонс
01:36 Google news Sci/TechOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue - Yahoo Finance

Oracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue  Yahoo FinanceOracle (ORCL) earnings Q1 2020: Mark Hurd takes leave of absence  CNBCOracle Co-CEO Mark Hurd Taking Medical Leave  The Wall Street JournalOracle stock slips as revenue comes up short, Hurd takes leave  MarketWatchOracle Earnings Miss, Co-CEO Takes Leave Of Absence  Investor's Business DailyView full coverage on Google News

Скрыть анонс
01:12 Google news Sci/TechIn a CRISPR first, therapy aiming to cure HIV patient appears safe - STAT

In a CRISPR first, therapy aiming to cure HIV patient appears safe  STATCRISPR Gene-Editing Shows Promise As HIV Cure, Research Shows : Shots - Health News  NPRChinese Scientists Try to Cure One Man's HIV With Crispr  WIREDCRISPR-Edited Cells That Block HIV Last Over a Year Without Side Effects, Study Shows  ScienceAlertChinese Scientists Tried to Treat HIV Using CRISPR  Livescience.comView full coverage on Google News

Скрыть анонс
01:00 LiveScience.comChinese Scientists Tried to Treat HIV Using CRISPR

Scientists in China have attempted to use CRISPR gene-editing technology to treat a patient with HIV.

Скрыть анонс
00:20 Nature.Com Scientists use gene-edited stem cells to treat HIV — with mixed success

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
00:02 Reuters.com TechnologyOracle CEO Mark Hurd to take leave on health grounds; misses quarterly revenue

Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a leave of absence due to health-related reasons, and the business software maker posted first-quarter revenue that missed Wall Street expectations.

Скрыть анонс
00:02 Google news Sci/TechOracle CEO Mark Hurd to take a leave of absence for health reasons - CNBC

Oracle CEO Mark Hurd to take a leave of absence for health reasons  CNBCOracle CEO Mark Hurd to take leave on health grounds  Yahoo FinanceOracle CEO Mark Hurd is taking a leave of absence, saying he needs 'time focused on my health'  Business InsiderOracle CEO Mark Hurd to Take Leave to Focus on Health  BloombergOracle Chief Executive Officer Mark Hurd to Take a Leave of Absence for Health Related Reasons  Yahoo FinanceView full coverage on Google News

Скрыть анонс
11.09.2019
23:50 FT.com TechnologyOracle co-chief Mark Hurd to take leave of absence for health reasons

Technology sector

Скрыть анонс
23:50 Reuters.com TechnologyOracle CEO Mark Hurd to take leave on health grounds

Oracle Corp said on Wednesday Chief Executive Officer Mark Hurd would be taking a leave of absence due to health-related reasons.

Скрыть анонс
23:26 CNBC technologyOracle CEO Mark Hurd to take a leave of absence for health reasons

Co-CEO Mark Hurd is taking a leave of absence, the company said.

Скрыть анонс
23:26 CNBC top newsOracle CEO Mark Hurd to take a leave of absence for health reasons

Co-CEO Mark Hurd is taking a leave of absence, the company said.

Скрыть анонс
23:14 Google news Sci/TechEmbryo-like structures created from human stem cells - Nature.com

Embryo-like structures created from human stem cells  Nature.com'Synthetic' Human Embryoids Can Now Be Mass-Produced : Shots - Health News  NPRMeet the artificial embryos being called “uncanny” and “spectacular”  MIT Technology ReviewMeet the artificial embryos people are calling “uncanny” and “spectacular”  MIT Technology ReviewView full coverage on Google News

Скрыть анонс
22:13 ScienceMag.orgSome cancer drugs miss their target. CRISPR could improve their aim

Method that generated drug leads may be flawed

Скрыть анонс
21:50 News-Medical.NetCombining exercise and calorie restriction could be bad for bone health

A new study published today in the Journal of Bone and Mineral Research shows how bones in mammals are negatively impacted by calorie restriction, and particularly by the combination of exercise and calorie restriction.

Скрыть анонс
20:12 Nature.ComEmbryo-like structures created from human stem cells

Скрыть анонс
20:12 Nature.ComControlled modelling of human epiblast and amnion development using stem cells

Скрыть анонс
16:56 Medscape.ComFor-Profit Dialysis Units Referring Less for Transplant?

A recent study shows that patients at for-profit dialysis units are less likely to be placed on the transplant waitlist than patients at non-profit units. What's going on?

Скрыть анонс
15:56 News-Medical.NetGyros Protein Technologies launches Gyrolab p24 Kit for scientists in cell and gene therapy market

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® p24 Kit, for lentivirus titer determination in lentivirus vector manufacturing.

Скрыть анонс
15:41 ScienceDaily.comCancer research: The genetic context is crucial

A team has uncovered a mechanism behind the variability in the clinical course of Ewing sarcoma. The interaction between the acquired driver mutation and the germline genetic context in which it occurs determines the course of the disease.

Скрыть анонс
12:42 Technology.orgIs treatment forever? Success of gene therapy for inherited blindness depends on timing

Nearly two decades ago, a gene therapy restored vision to Lancelot, a Briard dog who was born with

Скрыть анонс
09:02 Technology.orgStudy finds kidney dialysis profit status may influence timeline for receiving transplant

Patients with end-stage kidney disease who receive dialysis at for-profit dialysis centers are less likely to receive a

Скрыть анонс
07:18 News-Medical.NetBrain-computer interface: huge potential benefits and formidable challenges

A new Royal Society report called “iHuman: blurring lines between mind and machine” is for the first time systematically exploring whether it is “right” or not to use neural interfaces – machines implanted in or worn over the body to pick up or stimulate nervous activity in the brain or other parts of the nervous system.

Скрыть анонс
03:08 BBC HealthVaginal fluid transplants may soon be available in US

Doctors believe some women with repeat infections could benefit from the procedure.

Скрыть анонс
02:47 News-Medical.NetSupercooling helps preserve human transplant organs longer

Now a new supercooling technique for human organs promises to extend the period from the moment of removal to 1.5 days rather than just a few hours. This provides a useful window of time within which transplant teams and patients can hope to get a viable organ.

Скрыть анонс
00:38 Reuters.com HealthPatients at for-profit dialysis centers less likely to get kidney transplants

(Reuters Health) - The likelihood that U.S. patients with renal failure will get a kidney transplant is lower for those who get dialysis at for-profit dialysis centers, a new study shows.

Скрыть анонс
10.09.2019
21:55 ScienceDaily.comHow salamanders harness limb regeneration to buffer selves from climate change

Researchers have shown for the first time that salamanders inhabiting the Southern Appalachian Mountains use temperature rather than humidity as the best cue to anticipate changes in their environment. Significantly, they observed that these salamanders actually harness their unique ability to regenerate limbs to rapidly minimize the impact of hot temperatures. The findings may have implications for other animals and even plants.

Скрыть анонс
19:49 Phys.orgStudy shows how salamanders harness limb regeneration to buffer selves from climate change

Looking like a cross between a frog and a lizard, the gray cheek salamander has thin, smooth skin and no lungs. The amphibian breathes through its skin, and to survive it must keep its skin moist. As environmental conditions grow hotter or drier, scientists want to know whether and how these animals can acclimate.

Скрыть анонс
19:36 News-Medical.NetNanocapsules packed with gene-editing tools could be promising platform for many gene therapies

New tools for editing genetic code offer hope for new treatments for inherited diseases, some cancers, and even stubborn viral infections. But the typical method for delivering gene therapies to specific tissues in the body can be complicated and may cause troubling side effects.

Скрыть анонс
15:38 FierceBiotech.comKleiner, GV drive gene editing startup Trucode to $34M round

Kleiner Perkins and GV have powered Trucode Gene Repair to a $34 million financing round. Trucode will use the money to advance gene editing assets designed to correct the mutations behind diseases including sickle cell and cystic fibrosis. 

Скрыть анонс
14:03 Phys.orgNanotherapy: Controlled delivery of chemotherapeutics to fight cancer stem cells

Chemotherapy is one of the most used treatments against cancer, along with surgery and radiotherapy. In a chemotherapy treatment, one or several drugs are administered to the patient to remove or damage cancer cells. Nevertheless, the treatment has several drawbacks that are hard to overcome, particularly the side effects. In this case, the inherent toxicity of the drugs employed causes a variety of symptoms including weakness, nausea and hair loss. As a result, chemotherapy is far from an ideal approach.

Скрыть анонс
11:15 Technology.orgTiny capsules packed with gene-editing tools offer alternative to viral delivery of gene therapy

New tools for editing genetic code offer hope for new treatments for inherited diseases, some cancers, and even

Скрыть анонс
First← Previous12345678910Previous →Last